Kidney disease is a growing health concern, affecting millions of people around the world. For patients with chronic kidney disease, treatment often involves dialysis, which can be time-consuming, costly, and burdensome. However, a Canadian medical devices company called NephroCan is looking to revolutionize the way kidney disease is treated, providing patients with a new, more effective, and efficient option.
By Mohammed Irshad
NephroCan’s CEO DelaramHajipour attributed the company’s success to its innovative approach to renal care. By focusing on developing products that cater to patients with kidney failure, NephroCan has established itself as a one-of-a-kind fully integrated product and service provider for hemodialysis patients.Unlike other companies that only provide machine equipment or disposable devices, NephroCan produces both in-house, making it easier for healthcare providers to source all their needs from a singular partner. This unique and distinguishing factor has positioned itself as a leader in the field.
“NephroCan is dedicated to improving the lives of patients living with End Stage Renal Disease (ESRD) by providing a comprehensive hemodialysis treatment package to healthcare providers and being an all-encompassing partner. Our unique approach, which includes design, manufacture, and servicing, along with the necessary post-sales support, ensures we deliver quality and affordability at every step.” Hajipour told Mediworld ME in an email interview.
NephroCan has established its base in Vancouver, Canada, a city renowned for its technology hub and innovative spirit, often dubbed as the ‘Silicon Valley of the North.’ The headquarters allow NephroCan to utilize the latest advancements in design, strategy, and technology to develop safe, user-friendly, and effective healthcare products. With a focus on close collaboration with healthcare professionals, engineers, and patients, NephroCan ensures that its products meet the needs of its users. An in-house nurse also supports healthcare providers and patients in addressing their requirements.
Innovative Hemodialysis Solution
As they venture into the realm of accessible renal care, NephroCan places a significant emphasis on investing in research and development endeavors, “Our priority is to look at the future of accessible renal care,” said CEO Hajipour. Specifically, for the hemodialysis machine, NephroCan collaborated with dialysis nurses, nephrologists, and engineers to create a product that’s user-friendly, compact, and extremely precise. “As the industry conversation heads toward home dialysis, NephroCan has both the infrastructure and expertise to be an active participant and contributor in this shift,” Hajipour added.
Established in response to the growing interest in Canadian medical devices, NephroCan conducted a detailed feasibility study to understand the industry landscape before entering the market. In 2016, NephroCan was established as a fully integrated product and service provider for hemodialysis patients. “We’re allowing healthcare providers to source all their needs from a singular partner, and this is our unique and distinguishing factor,” said Hajipour.
Dedicated to delivering affordable, high-quality, and innovative hemodialysis treatment solutions, NephroCan has accomplished remarkable milestones, including building its own cutting-edge manufacturing line. “Our commitment to excellence and innovation drives us to improve and expand our existing product line, with ESRD patients at the forefront of every decision,” said Hajipour. “Striving to advance patient care globally has led us to partnerships with renowned experts in the field, allowing us to push the boundaries of what’s possible for hemodialysis treatment.”
According to Hajipour, “our team has accomplished a lot, but we’re not done yet. We’re constantly looking for ways to improve and innovate in order to provide the best possible care to hemodialysis patients.”
Accessible Care
NephroCan is a medical device company founded on the principle that every hemodialysis patient deserves tailored therapy. “Our range of high-quality disposable devices and machinery equipment caters to the individualized treatment needs of every patient, regardless of geographical location, facility, or quantities needed,” explained CEO DelaramHajipour.
According to Hajipour, NephroCan offers several customization options to ensure that patients receive the best possible care. “For example, we offer the ability for the dialysis chair to be paired with a patient weight scale, a modular central reverse osmosis machine, where additional filters can be added as a clinic grows to accommodate more treatments, and a hemodialysis machine that can be fitted with one, two or three pumps, depending on the recommendation of the nephrologist for patient treatment.”
NephroCan has established strategic partnerships with esteemed entities worldwide, representing their products in key regions such as the European Union, the MENA region, and other areas of Africa. “By collaborating with these esteemed partners, we aim to ensure that our products and services are easily accessible to healthcare professionals, thereby fulfilling our mission of improving the lives of ESRD patients in the Middle East but also globally,” said Hajipour.
The company attends and exhibits at Arab Health, the leading healthcare conference in the Middle East, where they build long-term relationships with key industry contacts. “We continue to expand our reach by working with more like-minded partners who share our vision,” Hajipour added.
Hemodialysis InnovationAhead
One of NephroCan’s achievements is its ISO 13485 and CE certifications, which attest to the safety and quality of its medical devices. “These certifications enable us to sell and distribute our products not only in the European Union but also in other countries that recognize CE certification,” Hajipour explained. The company’s team of experienced quality managers ensures that every product meets the highest standards of consistency and precision.
NephroCan is currently working on a home care solution project, which is slated to launch within the next two to three years. The machine will be specifically designed to meet the unique needs of patients receiving treatment in their homes. “Our goal is to provide patients with greater freedom, comfort, and convenience in receiving care,” Hajipour said. The company’s extensive experience in the field and foundation from its current hemodialysis machine will be instrumental in designing and manufacturing high-quality equipment suitable for home treatment.
The global concern of chronic kidney disease is increasing, with an estimated 6.8% compound annual growth rate of patients requiring dialysis in the next ten years. Home dialysis is seen as a promising solution, particularly in the wake of the COVID-19 pandemic, which has emphasized the importance of remote healthcare. NephroCan is leading the charge in designing and manufacturing equipment for home treatment, committed to improving the lives of ESRD patients and rethinking hemodialysis to make a lasting impact on the future of renal care.
NephroCan’s commitment to innovation and quality has earned the company strategic partnerships with esteemed entities worldwide, with its products now utilized in key demographics such as the European Union, the MENA region, and other areas of Africa. By collaborating with like-minded partners, NephroCan is ensuring that its products and services are easily accessible to healthcare professionals, thereby fulfilling its mission of improving the lives of ESRD patients globally.
